Log In
Print this Print this

AECase (AEB3103)

  Manage Alerts
Collapse Summary General Information
Company Aeglea BioTherapeutics Inc.
DescriptionEngineered and PEGylated human cysteine/cystine degrading enzyme
Molecular Target Cysteine protease
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPreclinical
Standard IndicationHematologic malignancies
Indication DetailsTreat hematologic malignancies
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today